Data from a pilot study on a new prototype photodynamic therapy device for BCC was shown at the EADV Congress.
Case-based observations offered clinicians real-world guidance on distinguishing underlying malignancies in the Therapeutic Hotline session at Maui Derm NP+PA Fall 2021.
At Maui Derm NP+PA Fall 2021, George Martin, MD, discussed his opinion on best treatment options for SCC in situ and cutaneous SCC at high risk for metastasis along with BCC that require special considerations.
A review of the American Academy of Dermatology guidelines and current treatment improvements for actinic keratosis were discussed during a presentation at Maui Derm NP+PA Fall 2021.
The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
New study data shows positive data for Image-Guided Superficial Radiotherapy (IGSRT) in treating basal cell carcinoma and squamous cell carcinoma.
Skin cancer rates have been increasing worldwide, and climate change factors – like depleting ozone layers – may be a factor.
It has been 20 years since the FDA approved a new sunscreen filter. However, a recent study evaluating curcumin could change that.
There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed.